Kuala Lumpur – Ramadan is a month of solidarity and Muslims in Malaysia take the opportunity to increase the amount of charitable acts during this period to help the less fortunate and underprivileged who may not get to experience the joy of the holy month.
Kuala Langat JUNE 6, 2018 – Ramadan is a time for good deeds and helping out the less fortunate. While most children in Malaysia celebrate the holy month with their family and friends, let us remember and help the underprivileged children who do not have the opportunity to enjoy the blessings of Ramadan with their loved ones. In the true spirit of Ramadan, CCM Duopharma Biotech Berhad (CCM Duopharma) recently hosted 32 underprivileged children of Rumah Titian Kasih Al-Inayah, aged between six and 17, to a buka puasa session to spread the joy of the holy month.
SHAH ALAM MAY 31, 2018 – Shareholders of CCM Duopharma Biotech Berhad (CCM Duopharma) at its Extraordinary General Meeting (EGM) today approved the resolution to credit 371,945,333 new ordinary shares as fully paid-up on the basis of four bonus shares for every three existing CCM Duopharma shares and also a dividend reinvestment plan (DRP) which provide the shareholders with an option to reinvest their cash dividend in the Group’s shares.
Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) recorded a 10.14 per cent growth in Revenue for the first quarter ended March 31, 2018 to RM133.26 billion from RM120.99 million in the same quarter last year. The Group’s Profit before Tax for the first quarter rose 18.60 per cent to RM13.26 million from RM11.18 million in the same period last year while Profit after Tax jumped 23.54 per cent to RM10.65 million from RM8.62 million in the previous year.
Imagine a crowd of over 500 applauding, giving you their utmost respect the moment you step on a stage. You are presented with a prestigious award sought after by many budding pharmacists. However, not everyone knows the sheer grit and determination that ultimately led to the success.
Kuala Lumpur APRIL 30, 2018 – Handicraft made with love by children with autism will be showcased throughout Malaysia, thanks to Champs, Malaysia’s largest vitamin brand for children which is collaborating with the National Autism Society of Malaysia (NASOM) to create greater awareness and acceptance of autism, besides enabling the latter’s products to be appreciated by a wider market.
Kuala Lumpur April 25, 2018 – CCM Duopharma Biotech Berhad (CCM Duopharma) has raised RM5,000 in funds, through its “Wear Green for Charity” campaign, for the MAA Medicare Charitable Foundation which offers subsidised dialysis treatment to needy patients who are suffering from chronic kidney disease.
Bangi APRIL 3, 2018 – CCM Duopharma Biotech Berhad (Duopharma) expects its newly completed Effervescent plant in Bangi, the country’s first ever such facility, to put the Company at the forefront of technology development in manufacturing high-quality pharmaceutical products using Effervescent technology that offers advantages over conventional manufacturing of healthcare products.
Kuala Lumpur – Popularity of CCM Duopharma Biotech Berhad (Duopharma) sponsored drama series titled ‘Lafazkan Kalimah Cintamu’ has boosted sales of Flavettes Effervescent significantly due to the drama’s high rating and trending on the social media recently.
Bangi, Selangor – CCM Duopharma Biotech Berhad’s (Duopharma) effort in intensifying its Halal integrity in the Halal pharmaceutical sector was further endorsed via the visit of Datuk Dr. Zulkifli Bin Mohamad Al-Bakri, Mufti of the Federal Territory, to its manufacturing plant located in Bangi recently.
Kuala Lumpur, February 27 2018 – CCM Duopharma Biotech Berhad (Duopharma) has proposed a bonus issue of up to 371,945,333 new ordinary shares on the basis of four (04) bonus shares for every three (03) existing shares, reflecting the company’s stronger fundamentals after it completed its demerger exercise earlier this year. Its Group Managing Director, Leonard Ariff Abdul Shatar said the bonus issue is aimed at rewarding existing shareholders for their loyalty and continuous support as well as increasing the share capital of the company to a level that will better reflect the current scale of operations and assets employed by Duopharma and its subsidiaries. In the statement to the local bourse today, Duopharma also announced that it is declaring its final dividend of six (06) sen per share and the Company is proposing to undertake the Proposed Dividend Reinvestment Plan (DRP), whereby the shareholders will be given the option to elect to reinvest the whole or part of the dividend into new ordinary shares of Duopharma.
Kuala Lumpur, February 27 2018 – CCM Duopharma Biotech Berhad (Duopharma) has proposed a bonus issue of up to 371,945,333 new ordinary shares on the basis of four (04) bonus shares for every three (03) existing shares, reflecting the company’s stronger fundamentals after it completed its demerger exercise earlier this year.
Kuala Lumpur – CCM Duopharma Biotech Berhad (CCMD) has entered into a collaboration with Natco Pharma Ltd of India to commercialise a range of Hepatitis C products in Malaysia to improve access and affordability for patients who currently have to fork out large sums of money for treatment in the country.
Kuala Lumpur – Once considered rare, autism is now on the rise and approximately 67 million worldwide live with autism. According to the Malaysian Department of Social Welfare, there are close to 13,000 individuals in Malaysia who are registered as autistic in 2014. Meanwhile, the Malaysian Ministry of Health reported that autism cases in the country are on the rise every year, emphasising the importance of early treatment to improve a child’s development.